Clinical management of epidermal growth factor receptor mutation-positive non-small cell lung cancer patients after progression on previous epidermal growth factor receptor tyrosine kinase inhibitors: The necessity of repeated molecular analysis

1. González-Larriba, J.L.
2. Lázaro-Quintela, M.
3. Cobo, M.
4. Dómine, M.
5. Majem, M.
6. García-Campelo, R.